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The histidine-containing dipeptides carnosine (CAR) and structurally related anserine (ANS) and
homocarnosine (HCAR), widely distributed in vertebrate organisms, have recently been proposed
as endogenous quenchers for highly cytotoxic a,b-unsaturated aldehydes generated by peroxidation.
A sensitive, selective, specific and rapid liquid chromatographic/electrospray ionization tandem mass
spectrometric assay was developed and validated for the simultaneous determination of these peptides
in biological matrices in order to establish their plasma/tissue distribution. Samples (plasma or tissue
homogenates from male rats) were prepared by protein precipitation with HClO4 (1 : 1, v/v) containing
H-Tyr-His-OH as internal standard. The supernatant was separated on a Phenomenex Sinergy polar-RP
columnwith amobile phase ofwater–acetonitrile–heptafluorobutyric acid (9 : 1 : 0.01, v/v/v) at a flow-rate of
0.2 ml min−1, with a run time of 10 min. Detection was effected on an ion trapmass spectrometer equipped
with an electrospray ionization interface operating in positive ionization mode. The acquisitions were in
the multiple reaction monitoring mode using the following precursor → product ion combinations: H-
Tyr-His-OH (internal standard)m/z 319 → 301; CARm/z 227 → 210 + 209; ANSm/z 241 → 224 + 197 + 170;
HCAR m/z 241 → 156. The method was validated over the concentration range 15–1000 nmol g−1 and the
limit of quantification (LOQ) and limit of detection (LOD) were 12.5 and 4.2 pmol injected, respectively.
The intra- and inter-day precisions were <10% (≤17.47% at the LOQ) and the intra- and inter-assay
accuracies were within ±10% for all concentrations. The mapping profile in rat tissue gave the following
results: the highest concentrations of CAR andANSwere found in skeletalmuscles (soleus, gastrocnemius,
tibialis), followed by the heart, cerebellum and brain (ANS below the LOQ). HCAR was found only in the
brain and cerebellum. No histidine-containing dipeptides were detectable in plasma, liver, kidney and
lung. Copyright  2004 John Wiley & Sons, Ltd.
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INTRODUCTION
Carnosine (CAR) (ˇ-alanyl-L-histidine), homocarnosine
(HCAR) (-aminobutyryl-L-histidine), anserine (ANS) (N-
ˇ-alanyl-3-methyl-L-histidine) and balenine (BAL) (N-ˇ-
alanyl-1-methyl-L-histidine) are histidine-containing dipep-
tides widely distributed in vertebrate animal tissues, espe-
cially skeletal muscles, heart and the central nervous system.
Although their biological role is still not known, there is
evidence that they act as intracellular buffers, immune modu-
lators, neurotransmitters (GABA precursor), metal-ion chela-
tors, antioxidants and free-radical scavengers.1 – 6 It has been
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suggested that CAR could act as a detoxifying agent for cyto-
toxic reactive carbonyl species, especially ˛,ˇ-unsaturated
aldehydes (4-hydroxynonenal (HNE) and acrolein (ACR))
generated in vivoby metal-catalyzed oxidation of ω-6 polyun-
saturated fatty acids such as arachidonic and linoleic acids.7 – 9
We recently confirmed this10 – 12 by studying the quench-
ing capacity of CAR, HCAR and ANS towards HNE and
ACR and elucidating the adduction reaction mechanism
(mass spectrometric (MS) and NMR characterization of the
conjugated products). The carbonyl quenching ability of
CAR and ANS has been confirmed by liquid chromato-
graphic/tandem mass spectrometric (LC/MS/MS) analysis
(electrospray ionization (ESI) interface) in complex biologi-
cal matrices (spontaneously oxidized rat skeletal muscle),11
suggesting that this tissue, highly exposed to peroxidative
attack, contains a histidine-dependent detoxification path-
way against cytotoxic HNE alternative/concomitant to that
involving thiol-containing peptides (i.e. GSH).
Copyright  2004 John Wiley & Sons, Ltd.
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In view of the growing interest and the biological
importance of histidine-containing dipeptides, there is a
definite need for a sensitive, specific and simple analytical
method to detect these compounds in biological matrices.
Several methods, mainly high-performance liquid chromato-
graphic (HPLC) (reversed-phase or ion-exchange), have been
described for the analysis of histidine-containing dipeptides
in matrices from different mammalian species. UV detec-
tion has been applied to underivatized peptides,13,14 but on
account of the low extinction coefficients, precolumn deriva-
tization with different chromophores and fluorophores or
post-column derivatization (by o-phthalaldehyde or ninhy-
drin) has been used more often.15 – 21
All these methods suffer from several drawbacks: low
resolution, instability of derivatives, in some cases a high
detection limit, and above all, they require complex and
extensive sample processing and are tedious and time
consuming. The most recent methods (HPLC) have only
been used to search for histidine-containing peptides in
feeds (to check for products of animal origin), and not
in ex vivo animal tissues.22 – 24 Surprisingly, MS has never
been employed for this purpose, despite the well-known
specificity and sensitivity of ESI for peptides.
We therefore designed this study to assess the potential
of an LC/ESI-MS/MS approach for profiling histidine-
containing dipeptides in the rat (plasma and tissues), a field
not hitherto explored.
EXPERIMENTAL
Chemicals
All chemicals and reagents were of analytical grade, pur-
chased from Sigma-Fluka-Aldrich Chemical (Milan, Italy).
HPLC-grade and analytical-grade organic solvents were pur-
chased from Merck (Bracco, Milan, Italy). HPLC-grade water
was prepared with a Milli-Q water purification system (Mil-
lipore, Bedford, MA, USA). Carnosine (ˇ-alanyl-L-histidine)
and the internal standard (IS) H-Tyr-His-OH were gener-
ous gifts from Flamma (Chignolo d’Isola, Bergamo, Italy).
Homocarnosine (-aminobutyryl-L-histidine) and anserine
(N-ˇ-alanyl-3-methyl-L-histidine) and the protease inhibitor
cocktail were purchased from Sigma (Milan, Italy) and hep-
tafluorobutyric acid (HFBA) from Aldrich (Milan, Italy).
Balenine (N-ˇ-alanyl-1-methyl-L-histidine) was isolated from
porcine muscle (Longissimus dorsi) as described by Aristoy
et al.23
Instrumentation
LC/MS experiments were carried out on a Thermoquest
Surveyor LC system equipped with a quaternary pump,
a Surveyor UV/VIS diode-array programmable detector
6000 LP, a Surveyor AS autosampler, a vacuum degasser,
Xcalibur software and connected to a Thermo Finnigan
LCQ Advantage ion trap mass spectrometer (ITMS) (Thermo
Finnigan Italia, Milan, Italy). Separations were performed by
reversed-phase elution with a Phenomenex Sinergy polar-
RP column (150 ð 2 mm i.d., particle size 4 µm) (Chemtek
Analytica, Anzola Emilia, Italy) protected by a polar-RP
guard column (4 ð 2 mm i.d., 4 µm) thermostated at 25 °C.
Water–acetonitrile–HFBA (9 : 1 : 0.01, v/v/v) was the mobile
phase delivered at a flow-rate of 0.2 ml min1; the samples
rack was maintained at 4 °C. The ESI-MS source was set
at capillary temperature 200 °C, spray voltage 4.5 kV and
capillary voltage 21 V. The flow-rate of the nebulizer gas
(nitrogen) was 5 l min1. MS conditions and tuning were
achieved by mixing aqueous analyte solutions (flow-rate
5 µl min1) with the mobile phase through a T-connection at
a flow-rate of 0.2 ml min1.
Collision-induced dissociation (CID) experiments in the
positive ion mode were run by selecting the target ion with
an isolation width of m/z š0.5 and using helium as collision
gas. The ion collision energy was adjusted by changing a
percentage of the 5 V a.c. voltage which was applied to the
end-caps of the ion trap at the resonance frequency of the
selected ion and set at 30% (referred to as collision energy
level).
Acquisitions were taken in the multiple reaction monitor-
ing (MRM) mode using the following precursor ! product
ion combinations: H-Tyr-His-OH (IS) m/z 319 ! 301; CAR
m/z 227 ! 210 C 209; ANS m/z 241 ! 224 C 197 C 170;
HCAR m/z 241 ! 156.
Preparation of calibration standards and quality
control samples
Two fresh stock solutions of 10 mM CAR, ANS, HCAR and
the IS were prepared separately in 10 mM phosphate buffer
solution (PBS, pH 7.4) and stored in liquid nitrogen. One
solution was used to spike lung homogenate for calibration
samples and the other to prepare the quality control (QC)
samples (lung homogenate) and to spike tissue extracts.
Stock solutions were diluted further with PBS and the
solutions of each analyte were mixed together to obtain
working solutions. Working solutions of 100 nmol ml1 were
analyzed by LC/MS/MS to ensure that the concentrations
of the original solutions were within the limits of the
maximum established error (3%). Calibration samples were
prepared by spiking lung homogenate (1 : 3, w/v, in PBS)
with each working solution to provide the following final
concentrations: 15, 30, 150, 300, 450, 750 and 1000 nmol g1
wet mass tissue. QC samples at three concentrations (15,
150, 750 nmol g1) were prepared in the same way. Each
calibration sample was processed as described below.
Sample processing
Male Wistar rats (Charles River, Calco, Italy; body mass
250 š 25 g) were maintained in compliance with the policy
on animal care expressed in National Research Council
guidelines (NRC 1985). Laboratory chow and drinking water
were available ad libitum.
The animals were killed by decapitation and the blood
was collected in heparinized test-tubes and tissues (soleus,
gastrocnemius and tibialis skeletal muscles, heart, brain,
cerebellum, kidney, lung, liver) were removed and stored
in liquid nitrogen until processed. Blood was centrifuged at
1000 g for 15 min at 4 °C. The plasma was removed and stored
in liquid nitrogen until analysis. Tissues were homogenized
in cold PBS (1 : 3, w/v, heart, brain, cerebellum, kidney, lung,
liver; 1 : 30, w/v, for skeletal muscles) containing protease
inhibitor cocktail (50 µl g1 wet tissue). Aliquots of 500 µl
Copyright  2004 John Wiley & Sons, Ltd. J. Mass Spectrom. 2004; 39: 1417–1428
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of the homogenate were spiked with IS (50 µl of a 4 mM
solution), deproteinized by addition of 500 µl of 700 mM
perchloric acid (PCA) solution and vortex mixed for 1 min.
After 15 min at 4 °C, the samples were centrifuged at 21 000 g
for 10 min. The supernatant was diluted (1 : 1, v/v) with
the mobile phase, filtered through 0.2 µm nylon filters and
the filtrate transferred to the autosampler vial insert (10 µl
samples injected).
Validation of the method
Calibration standards were prepared and analyzed in
duplicate in three independent runs. The calibration curves
were constructed by weighted (1/x) least-square linear
regression analysis of the peak area ratios of CAR, ANS
and HCAR to the IS against nominal analyte concentration.
Intra- and inter-day precisions and accuracies of the
method were determined by assaying four replicates of
each of the QC samples (three concentrations in the low,
intermediate and high concentration ranges) in three separate
analytical runs. Precision and accuracy were determined by
calculating the coefficient of variation (CV, %) and the relative
error (RE, %). Precision and accuracy should be within 15%
except at the limit of quantification (LOQ), where it should
not exceed 20%.
The absolute recovery of the analytes after protein
precipitation was determined by comparing the results
for QC samples (n D 3) at the three concentrations with
a corresponding set of spiked deproteinized lung tissues
(containing 100% of the theoretical concentration).
The stability of the analytes was investigated in the stock
and working solutions and in the final extract at 4 °C (rack
temperature) up to 24 h. The results were compared with
those for freshly prepared QC samples and the percentage
concentration deviation was calculated. The analytes were
considered stable when 90–110% of the initial value was
found.
To verify whether different tissue matrices affect the
ionization efficiency of the analytes, tissue extracts were
spiked with CAR, ANS and HCAR at 15 and 750 nmol g1
(brain, cerebellum, heart) and 1500 nmol g1 (skeletal mus-
cles) and the precision and accuracy (four replicates for each
concentration) were calculated as above.
RESULTS AND DISCUSSION
Optimization of LC and MS conditions
Although acetonitrile–water spiked with 0.1% trifluoroacetic
acid (TFA) as ion-pairing agent is commonly used as
mobile phase to separate peptides by reversed-phase high-
performance liquid chromatography (RP-HPLC), it was not
suitable for histidine-containing dipeptide analysis since
they co-elute near the void volume. Similar results were
obtained by raising the final concentration of TFA to
0.2%. Perfluorinated carboxylic acids with longer n-alkyl
chains, such as pentafluoropropionic, heptafluorobutyric,
perfluoropentanoic, perfluorohexanoic and perfluorohep-
tanoic acid, have been employed as alternatives to TFA
for the separation of polar peptides and proteins25,26 and
for natural amino acids27 and dipeptides.28 Thus, adequate
results were obtained using 0.1% HFBA as ion-pairing agent:
the histidine-containing dipeptides eluted at 4.54 min (CAR),
4.64 min (ANS, HCAR) and 5.06 min (BAL), with an excellent
bell shape. H-Tyr-His-OH was chosen as IS for quantitative
analysis because no isotopic derivatives of these compounds
are commercially available, and it eluted at 8.06 min.
The full mass spectra of CAR, HCAR, ANS, BAL and IS in
MS infusion experiments showed the protonated molecular
ions [M C H]C at m/z 227, 241, 241, 241 and 319, respectively
(Table 1). The effect of HFBA on the ionization efficiency is
shown in Fig. 1. Although HFBA suppressed the ion current
by almost 50% for CAR, ANS and BAL, the effect was much
less than that of the common ion-pairing agent TFA (ion
suppression >75%). By contrast, HFBA increased the HCAR
ion current by 35%, whereas TFA reduced it by 35%.
MS/MS experiments were carried out to determine
the optimal fragmentation reaction for MRM analysis.
For CAR, the most abundant product ions were at m/z
210 ([M C H  NH3]C) and 209 ([M C H  H2O]C) and for
HCAR at m/z 156 (y1 ion) (Table 1). There were three
main product ions for ANS and BAL, at m/z 224 ([M C
H  NH3]C), 170 (y1 fragment) and 197 ([M C H  CO2]C),
so we cannot discriminate the two N-methyl derivatives
of CAR. Since the ion at m/z 170 is attributed to the
protonatedN-methylhistidine moiety, and the fragmentation
patterns ofN1-methylhistidine andN3-methylhistidine differ
significantly,28 the ion atm/z 170 was submitted to CID (MS3)
in order to distinguish the two dipeptides. In agreement
with Turecek et al.,29 N1-methylhistidine arising from BAL
fragmentation showed a dominant loss of H2O C CO to form
a diagnostic fragment ion at m/z 124. By contrast, the N3-
methylhistidine fragment from ANS showed a characteristic
product ion at m/z 126 due to the loss of CO2. The two
isobaric species ANS and BAL can therefore be unequivocally
distinguished on the basis of the MS3 fragment ions at m/z
124 (BAL) and 126 (ANS). The positive full mass spectrum
of the IS showed the protonated molecular ion at m/z 319
and the MS/MS analysis of the parent ion gave as base peak
the ion at m/z 301 ([M C H  H2O]C) and a minor peak at
m/z 156 (y1 ion). On the basis of the MS
n fragmentation
pathways, we conclude that this approach can selectively
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Figure 1. Effects of HFBA and TFA on ionization efficiency of
CAR, HCAR, ANS and BAL. The experiments involved mixing
the analyte water solution (100 nmol ml1, flow-rate
5 µl min1) through a T-connection with the mobile phase at a
flow-rate of 0.2 ml min1.
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Figure 2. LC/MS and LC/MSn analysis (positive-ion mode) of a mixture of standard histidine-containing dipeptides. MS panel: SICs
at m/z 227 (a), 241 (b) and 319 (c). MSn experiments: MS2 was performed to detect and quantitate CAR (m/z 227 ! 210 C 209) and
HCAR (m/z 241 ! 156) and MS3 to discriminate between BAL (m/z 170 ! 124) and ANS (m/z 170 ! 126).
determine all the analytes, even if they are simultaneously
present, have similar retention times and three of them are
isobaric. This is clear from the LC/MS profiles of the four
dipeptides (Fig. 2), which can be selectively detected by the
following precursor–product ion combinations:
CAR: m/z 227 ! 210 C 209;
HCAR: m/z 241 ! 156;
ANS: m/z 241 ! 170, 197, 224; 170 ! 126 MS3;
BAL: m/z 241 ! 170, 197, 224; 170 ! 124 MS3;
IS: m/z 319 ! 301.
Qualitative analysis in tissues
The method was employed, before quantitation, to detect
the histidine dipeptides in rat tissues, starting from skeletal
muscle (gastrocnemius), which contains large amounts of
these derivatives. Figure 3 reports the results of injecting
the crude homogenate after a simple deproteinization
step by PCA: the total ion current (TIC) (a) shows a
sharp peak between 4.2 and 5.1 min, whose full mass
spectrum (b) contains two main peaks at m/z 227 and
241, eluting at 4.54 (c) and 4.64 min (d), respectively. These
two peaks can thus be attributed to CAR (m/z 227) and
to HCAR/ANS/BAL (m/z 241). As shown in Fig. 3, no
interfering peaks in the mass and time ranges of interest are
detectable, and no ionic species at m/z 319 ([M C H]C of the
IS) in the crude biological matrix.
Confirmation was obtained by MS2 and MS3 analyses.
Figure 4 unequivocally demonstrates CAR, since the full MS2
spectrum (parent m/z 227) contains all the typical product
ions of the compound (see Table 1). The full MS2 spectrum
of the parent ion m/z 241 (Fig. 4(d)) unequivocally excludes
HCAR (lack of m/z 156), but does not discriminate between
ANS and BAL. Again, this was achieved by MS3 analysis: the
full MS3 spectrum (parent ionm/z 170; Fig. 4(e)) indicates the
presence of ANS (diagnostic product ion at m/z 126) and the
absence of BAL (no product ion m/z 124). This is confirmed
by the corresponding selected reaction monitoring (SRM)
traces (Fig. 4(f)).
To test the specificity of this MS3 approach, pig ham,
which contains similar amounts of ANS and BAL,24 was
analyzed in parallel. Figure 5(a) reports the TIC of the
deproteinized muscle homogenate, showing a broad peak
eluting between 4.01 and 5.50 min; its full mass spectrum
(b) contains a prominent peak at m/z 227 attributed to CAR
Copyright  2004 John Wiley & Sons, Ltd. J. Mass Spectrom. 2004; 39: 1417–1428
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Figure 3. LC/MS analysis (positive-ion mode) of gastrocnemius skeletal muscle. (a) TIC; (b) full mass spectrum of the peak with
retention time 4.2–5.1 min; (c) SIC m/z 227 (CAR); (d) SIC m/z 241 (ANS/BAL/HCAR); (e) SIC m/z 319 (IS).
in MS2 experiments (data not shown) and a minor peak at
m/z 241. MS2 (c) and MS3 (d) spectra indicate the presence
of both ANS and BAL, confirmed by the corresponding SRM
traces (e) at m/z 124 (BAL) and 126 (ANS).
The LC/MS/MS approach was then applied to the
target rat tissues (data not shown), and the results can be
summarized as follows: CAR and ANS were detected in all
the skeletal muscles (gastrocnemius, tibialis and soleus),
Copyright  2004 John Wiley & Sons, Ltd. J. Mass Spectrom. 2004; 39: 1417–1428
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Figure 4. LC/MSn analysis (positive-ion mode) of gastrocnemius skeletal muscle. (a) Total reaction chromatogram (TRC) of the ion at
m/z 227 and (b) full MS2 spectrum of the peak at 4.54 min; (c) TRC of the ion at m/z 241, (d) full MS2 and (e) full MS3 (parent ion m/z
170) spectra of the peak at 4.64 min; (f) TRC of the ion atm/z 170 (upper panel) and SRM traces atm/z 124 (BAL) and m/z 126 (ANS).
and in myocardium and cerebellum, but only CAR in
brain. HCAR was present only in brain and cerebellum
and BAL was never found. None of the histidine-containing
dipeptides was detected in liver, lung and plasma.
Validation
Because of the absence of BAL in all rat tissues, quantitative
analysis was done only for CAR, HCAR and ANS. It was
impossible to validate the assay according to the FDA
guidelines for Bioanalytical Method Validation because
of the endogenous content of the analytes in the target
tissues (http://www.fda.gov/cder/guidance/4252fnl.htm).
Therefore, we executed a full validation procedure (linearity,
limit of detection (LOD), LOQ, intra- and inter-day precision
and accuracy, recovery and stability) on lung tissue, selected
as a reference blank matrix since it contains no CAR,
ANS or HCAR (see qualitative analysis). Standard curves
for the analytes constructed on different working days
showed good linearity over the entire calibration range
(15–1000 nmol g1), with correlation coefficients (r2) >0.998.
The equations for the calibration lines were as follows:
y D 0.003751 š0.000037x  0.004342 š0.004539 CAR
y D 0.003473 š0.000027x  0.005390 š0.003296 ANS
y D 0.000992 š0.0000089x  0.004724 š0.001096 HCAR
The LOD was 5 nmol g1 for all the analytes (4.2 pmol
injected) and the LOQ was 15 nmol g1 (12.5 pmol injected).
The intra- and inter-assay precision and accuracy of the
method were determined on QC samples by analysing four
replicates at three concentrations, and the data are reported
in Table 2. The intra-day precision (CV, %) was <14%
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Table 2. Intra- and inter-day accuracy and precision for CAR, ANS and HCAR
Analyte
Nominal concentration
(nmol g1)
Mean measured concentration
šSD nmol g1 CV (%) Accuracy (RE, %)
Intra-daya —
CAR 15 14.01 š 1.02 7.28 6.60
150 145.65 š 4.89 3.36 2.91
750 733.50 š 19.29 2.63 2.20
ANS 15 14.58 š 2.04 13.99 2.80
150 149.34 š 14.88 9.96 0.44
750 754.44 š 14.10 1.87 C0.59
HCAR 15 14.61 š 1.29 8.83 2.60
150 146.70 š 11.04 7.52 2.20
750 757.74 š 17.34 2.29 C1.03
Inter-dayb —
CAR 15 14.25 š 2.49 17.47 5.08
150 147.24 š 7.50 5.09 1.84
750 745.77 š 24.03 3.22 0.56
ANS 15 15.27 š 2.58 16.89 C1.80
150 145.38 š 9.75 6.71 3.08
750 746.52 š 13.68 1.83 0.46
HCAR 15 16.59 š 2.01 12.12 C10.08
150 142.23 š 9.84 6.92 5.18
750 746.91 š 19.65 2.63 0.41
a Four replicates at each concentration.
b Three runs, four replicates at each concentration over three days (n D 12).
and accuracy ranged from 6.60 to C1.03% of nominal
concentrations; the inter-day CV values were <17.5% and
accuracy was in the range 5.18 to C10.08%. Recoveries at
the two extremes of the calibration ranges were satisfactory,
ranging from 96.2 to 101.3% for all the compounds (data not
shown).
The stability of CAR, ANS and HCAR in aqueous
solutions and tissue extracts at room and higher temperatures
(up to 105 °C) has already been reported.23 We therefore
checked the stability of the analytes in QC samples and
in the spiked tissue extracts only under the experimental
conditions used. The stability was guaranteed for at least
24 h at 4 °C and no significant differences (t-test) were found
between freshly prepared homogenates and homogenates
prepared from tissues stored in liquid N2 (data not shown).
As shown in Table 3, precision and accuracy were
satisfactory in spiked deproteinized samples of all the
target tissues containing significant endogenous amounts
of the analytes. These results indicate that there are no
significant differences in the ionization efficiency between
lung and the tissue extracts considered, so calibration
curves prepared by spiking lung homogenate can be
used successfully to quantitate the analytes in the other
target tissues. Taking into account the dilution factor
(1 : 10) for skeletal muscle homogenate in comparison with
lung homogenate, the method allows quantitation up to
10 000 nmol g1.
Profile of histidine-containing dipeptides in rat
tissues
The method was then applied to profile the dipeptide
content in rat tissues (Fig. 6). Table 4 summarizes these
results: as reasonably expected, owing to the presence of
specific hydrolytic enzymes such as carnosinase,30 plasma,
liver and kidney do not contain histidine-containing dipep-
tides, which were also below the LOD in lung. There
were large amounts of CAR and ANS in all the skele-
tal muscles, in agreement with previous findings in the
rat31 and other animal species (horse, camel, cattle).18,24
It is worth noting that both of these dipeptides, but not
HCAR, are present in rat myocardium at significant lev-
els (¾50 nmol g1). This finding, not reported before, is
extremely important in the light of the well-documented
anti-ischemic activity of carnosine, demonstrated in the
isolated rat heart and in vivo.32 – 33 In addition, this is the
first study, to our knowledge, that unequivocally demon-
strates the presence of HCAR in brain and cerebellum by
an MS approach, since up to now it has only been detected
by HPLC with UV detection34 and by an immunochem-
ical approach.31 Immunochemical and radioimmunoassay
techniques, because of their high sensitivity, are widely
employed for detection and quantitation of peptides in bio-
logical matrices; anyway, as pointed out by Desiderio35,36
in two papers reviewing the analysis of peptides in tis-
sue extracts by different methodological approaches, the
MS/MS technique furnishes the highest level of molecular
specificity.
CONCLUSIONS
The proposed LC/MS/MS method, never before applied to
detect histidine-containing dipeptides in biological matrices,
requires minimal sample manipulation, including a very
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Figure 5. LC/MSn analysis (positive-ion mode) of ham. (a) TIC; (b) full mass spectrum of the peak with retention time 4.0–5.5 min;
(c) full MS2 (parent ion m/z 241) and (d) MS3 (parent ion m/z 170) spectra; (e) TRC of the ion at m/z 170 (upper panel) and SRM
traces at m/z 124 (BAL) and m/z 126 (ANS).
simple deproteinization step without further purification.
The method is fast (total analysis time 30 min, including
tissue homogenization, sample preparation and LC/MS
analysis) and sufficiently reliable, taking into account
that ion trap mass spectrometry is not the technique of
choice for quantitative analysis, providing less satisfactory
reproducibility (although always within the accepted criteria
in our case) than a three-stage quadrupolar system.
From a biological point of view, an analytical method
specifically intended to profile the levels of histidine-
containing dipeptides in the rat should help us to understand
better their biochemical role in different physio-pathological
conditions and to set up appropriate animal experiments, to
demonstrate their carbonyl quenching ability in vivo. In this
context, it is important that for the first time homocarnosine
(a potential neuroprotective agent and neurotransmitter in
human brain) was unequivocally detected and quantitated
in rat brain.
Another important field of application of this simple
approach would be the analysis of products of animal
origin in feeds (meat meal, meat bone meal, fish meal),
commonly used as valuable protein sources. In addition,
the analysis of histidine-containing dipeptides has been pro-
posed as an official method to detect products of animal
origin in feed for ruminants, forbidden in many jurisdic-
tions because of the increased risk of bovine spongiform
encephalopathy (BSE). To be successful for regulatory con-
trol of fraudulent/illegal use, analytical methods must
give unequivocal structure identification and be sensitive
and specific enough to allow the simultaneous detec-
tion of traces of dipeptides in different matrices. The
LC/MS/MS approach described seems to fulfil all these
requirements.
Finally, the method would also be helpful in experimental
animals and humans, to correlate the tissue content of CAR,
ANS and HCAR with physiological (aging) and pathological
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Table 3. Accuracy and precision for CAR, ANS and HCAR in spiked tissue extracts
Target tissue
Nominal concentration
(nmol g1) Analyte
Mean measured concentrationa
šSD nmol g1 CV (%)
Accuracy
(RE, %)
Heart 15 CAR 14.12 š 2.13 15.08 5.87
ANS 15.23 š 1.98 13.00 C1.53
HCAR 14.56 š 1.87 12.84 2.93
750 CAR 744.05 š 15.78 2.12 0.79
ANS 754.92 š 6.81 0.90 C0.66
HCAR 743.96 š 8.32 1.12 0.80
Brain 15 CAR 15.27 š 1.77 11.59 C1.80
ANS 14.65 š 1.12 7.64 2.33
HCAR 14.34 š 1.35 9.41 4.40
750 CAR 749.10 š 16.12 2.15 0.12
ANS 760.72 š 8.23 1.08 C1.43
HCAR 758.72 š 4.25 0.56 C1.16
Cerebellum 15 CAR 15.22 š 1.23 8.08 C1.47
ANS 14.56 š 1.13 7.76 2.93
HCAR 14.61 š 1.19 8.14 2.60
750 CAR 746.97 š 2.81 0.38 0.40
ANS 758.72 š 4.25 0.56 C1.16
HCAR 761.00 š 5.98 0.79 C1.47
Gastrocnemius skeletal muscle 1500 CAR 1483.10 š 37.88 2.55 1.13
ANS 1503.20 š 29.64 1.97 C0.21
HCAR 1514.84 š 15.76 1.04 C0.99
Tibialis skeletal muscle 1500 CAR 1526.44 š 16.38 1.07 C1.76
ANS 1512.44 š 18.10 1.20 C0.83
HCAR 1493.00 š 20.08 1.34 0.47
Soleus skeletal muscle 1500 CAR 1487.10 š 12.68 2.20 0.86
ANS 1517.34 š 17.18 1.13 C1.16
HCAR 1498.20 š 35.28 2.35 0.12
a Four replicates at each concentration.
Table 4. Profile of histidine-containing dipeptides in rat tissuesa
Tissue CAR ANS HCAR
Brain 27.35 š 7.56 n.d.b 51.14 š 6.10
Cerebellum 48.41 š 4.66 57.48 š 10.92 77.64 š 11.04
Kidney n.d. n.d. n.d.
Liver n.d. n.d. n.d.
Lung n.d. n.d. n.d.
Myocardium 67.03 š 3.45 64.50 š 9.86 n.d.
Plasma n.d. n.d. n.d.
Gastrocnemius skeletal muscle 5279.95 š 1006.21 7861.13 š 2599.12 n.d.
Tibialis skeletal muscle 4200.86 š 1093.41 7419.34 š 701.17 n.d.
Soleus skeletal muscle 2606.23 š 487.08 5414.51 š 1367.06 n.d.
a Values are mean šSD and are expressed as nmol g1 wet mass tissue.
b n.d., Below the LOD.
conditions (Alzheimer, atherosclerosis) involving a carbonyl-
mediated degenerative process.
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